LENZ Therapeutics, Inc.

LENZ Therapeutics, Inc. is a United States-based biopharmaceutical company focused on developing and commercializing innovative ophthalmic pharmaceutical products. The company is dedicated to addressing unmet needs in the treatment of presbyopia, also known as age-related blurry near vision, a condition that affects a significant portion of the aging population. Through rigorous research and development, LENZ Therapeutics aims to provide patients with effective and convenient solutions to improve their vision and quality of life. The company's pipeline focuses on novel formulations and delivery systems designed to optimize therapeutic outcomes and patient compliance. LENZ Therapeutics is committed to advancing the field of ophthalmology and becoming a leader in the development of innovative treatments for vision disorders.